Sign up USA
Proactive Investors - Run By Investors For Investors

PreveCeutical Medical Inc upgrades to OTCQB to expand US shareholder base

The index is for early-stage and developing United States and international companies, it said
PreveCeutical Medical Inc upgrades to OTCQB to expand US shareholder base
“We are extremely pleased to be able to upgrade to quote on the OTCQB," the firm said.

Health sciences group PreveCeutical Medical Inc (CSE: PREV, OTCQB: PRVCF) said shares began trading on the OTCQB Venture  Marketplace in the US on September 15.

The index is for early-stage and developing United States and international companies.

“We are extremely pleased to be able to upgrade to quote on the OTCQB.

"This listing will enable us to expand our US shareholder base as well as offer the company’s existing US shareholders a more transparent and efficient platform to obtain quotes and trade PreveCeutical securities," said PreveCeutical’s chairman and chief executive Stephen Van Deventer.

The group is developing innovative preventive therapies using organic and nature identical products and currently has five research and development programs.

These are dual gene therapy for curative and prevention therapies for diabetes and obesity; a Sol-gel platform for nose to brain delivery of medical compounds; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions.

The group also sells CELLB9, an immune system booster.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Related Articles

Proteomics International Laboratories: Access latest PPT from Proactive's CEO Sessions
April 12 2017
Richard Lipscombe talked revenue generation and growth path with investors.
Antibiotics
October 04 2017
US Food & Drug administration approval is yet to be granted but iclaprim, which has fast-track status, is closing in on the promised land.
Cellmid's Maria Halasz with investors at Proactive's CEO Sessions
October 05 2017
Maria Halasz discussed rapidly growing hair care sales at Proactive's CEO Sessions.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use